JCCC Research Seminar featuring Dr. Willy Hugo
Immune checkpoint inhibitor resistance in melanoma and glioblastoma: the contrast between the rich and the poor.
- Date: March 31, 2022 12:00 PM - 1:00 PM
- Location: Virtual event (registration required, see description)
10833 Le Conte Ave.
Los Angeles, California 90095
NOTE: This is event is being held virtually. Registration is required. Please visit this Zoom link to register and attend: cancer.ucla.edu/JCCCSeminarSeries.
Willy Hugo, PhD
Adjunct Assistant Professor, Department of Medicine, Dermatology
Dr. Willy Hugo earned his PhD in Computational Biology from the National University of Singapore in 2011. For his postdoctoral training, he worked under the mentorship of Dr. Roger Lo, focusing on analyzing the genome, transcriptome, methylome, regulome and proteome of patient and melanoma models (murine, patient-derived xenografts, cell lines). His research aims to study genes and pathways affecting melanoma's sensitivity/resistance toward targeted- and immunotherapies at single-cell level and translate such knowledge to improve patient treatment outcomes.
Light lunch served.
Sponsored by the UCLA Jonsson Comprehensive Cancer Center Signal Transduction and Therapeutics program.